Policy and Advocacy
Two Diseases, One Response
Globally, HIV and cervical cancer are major and mutually reinforcing health concerns. Women living with HIV are six times more likely to develop cervical cancer than those without HIV, and HPV infection (the primary cause of cervical cancer) doubles the risk of acquiring HIV.
A new amfAR policy brief highlights the intersection between HIV, HPV, and cervical cancer, with an emphasis on co-investment opportunities to advance elimination goals worldwide.
Your Source for HIV Data
amfAR maintains a series of free interactive databases to inform policymakers, public health officials, advocates, researchers, and other stakeholders about key aspects of the evolving U.S. and global HIV epidemics. These essential resources provide comprehensive data on global HIV programming/funding, key populations, the opioid epidemic, COVID-19, and the U.S. Ending the Epidemic plan.
Government Mandates Insurers Cover Long-Acting PrEP and Contraceptives
The rule changes require insurers to cover fully the cost of over-the-counter contraceptives and long-acting injectable PrEP for HIV prevention.
New Research Frontiers and Funding Fears
Reports of HIV cure research progress and a new PrEP option at the 25th International AIDS Conference were tempered by diminishing funding in treatment and prevention programs.
AIDS at a Crossroads
New global update from UNAIDS highlights progress but warns countries need to stay on track to end AIDS